In conclusion, our pan-cancer analysis of GBP1 indicated positive correlations between GBP1 and intratumoral immune infiltration, activation of immune-related pathways, and anti-tumor immune response in multiple cancer types. The gene discussed is GBP1; the disease is cancer.